Arginine residue 120 of the human GABA(A) receptor α1, subunit is essential for GABA binding and chloride ion current gating

NeuroReport

Volumn 10, Issue 11, 1999, Pages 2417-2421

  Westh Hansen, S E ^a   Witt, M R ^a   Dekermendjian, K ^a   Liljefors, T ^b   Rasmussen, P B ^c   Nielsen, M ^a  

^a Sct Hans Hospital   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NOVO NORDISK A S   (Denmark)

Author keywords

Electrophysiology; Mutation; Recombinant GABA(A) receptors; Sf 9 cells; subunit

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMINO ACID; ARGININE; BENZODIAZEPINE RECEPTOR; DIAZEPAM; FLUNITRAZEPAM; MUSCIMOL; TRITIUM;

ARTICLE; BINDING AFFINITY; CHANNEL GATING; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; ION CURRENT; MUTAGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING;

EID: 0033516983     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199908020-00036     Document Type: Article

References (25)

1. 1. Mehta AK and Ticku MK. Brain Res Brain Res Rev 29, 196-217(1999).
2. 2. Sieghart W. Pharmacol Rev 47, 181-234 (1995).
3. 3. McKeman RM and Whiting PJ. Trends Neurosci 19, 139-143 (1996).
4. 4. Sigel E and Buhr A. Trends Pharmacol Sci 11, 425-429 (1997).
5. 5. Westh-Hansen SE, Rasmussen PB, Hastrup S et al. Eur J Pharmacol 329, 253-257 (1997).
6. 6. Witt MR, Westh-Hansen SE, Rasmussen PB et al. J Neurochem 67, 2141-2145 (1996).
7. 7. Hirouchi M, Kuwano R, Katagiri T et al. Neurochem Int 15, 33-38 (1989).
8. 8. Schofield PR, Pritchett DB, Sontheimer H et al. FEBS Lett 244, 361-364 (1989).
9. 9. Birnir B, Tiemey ML, Pfflai NP et al. J Membr Biol 148, 193-202 (1995).
10. 10. Hartnett C, Brown MS, Vu J et al. Receptors Channels 4, 179-195(1996).
11. 11. Murase K, Randic M, Shirasaki T et al. Brain Res 525, 84-91 (1990).
12. 12. Verdoom TA, Draguhn A, Ymer S et al. Neuron 4, 919-928 (1990).
13. 13. Ebert B, Thompson SA, Saounatsou K et al. Mol Pharmacol 52, 115 0-115 6 (1997).
14. 14. Davias M, Baleson AN and Dunn SM. Front Biosci 1, D214-D233 (1996).
15. 15. Amin J, Dickerson IM and Weiss DS. Mol Pharmacol 45, 317-323 (1994).
16. 16. Buhr A, Schaerer W, Baur R et al. Mol Pharmacol 52, 676-682 (1997a).
17. 17. Buhr A, Baur R and Sigel E. J Biol Chem 272, 11799-11804 (1997b).
18. 18. Birnir B, Tierney ML, Lim M et al. Synapse 26, 324-327 (1997).
19. 19. Sigel E, Baur R, Kellenberger S et al. EMBO J 6, 2017-2023 (1992).
20. 20. Smith GB and Olsen RW. J Biol Chem 269, 20380-20387 (1997).
21. 21. Amin J and Weiss DS. Nature 366, 565-569 (1993).
22. 22. Chang Y, Wang R, Barot S et al. J Neurosci 16, 5415-5424 (1996).
23. 23. Im WB Pregenzer JF, Binder JA et al. Br J Pharmacol 120, 559-564(1997).
24. 24. Widdows KB, Kirkness EF and Turner AJ. FEBS Letters 222, 125-128 (1987).
25. 25. Frydenvang K, Matzen L, Noffby PO et al. J Chem Soc Park Trans II, 1783-1791 (1997).